Brepocitinib PO QD: Brepocitinib PO QD
Placebo PO QD: Placebo PO QD
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
| Facility | City | Region | Status |
|---|---|---|---|
| Clinical Trial Site | Phoenix | Arizona | |
| Clinical Trial Site | Phoenix | Arizona | |
| Clinical Trial Site | Bakersfield | California | |
| Clinical Trial Site | Beverly Hills | California | |
| Clinical Trial Site | Fullerton | California | |
| Clinical Trial Site | Irvine | California | |
| Clinical Trial Site | La Jolla | California | |
| Clinical Trial Site | Los Angeles | California | |
| Clinical Trial Site | Los Angeles | California | |
| Clinical Trial Site | Modesto | California | |
| Clinical Trial Site | Sacramento | California | |
| Clinical Trial Site | Aurora | Colorado | |
| Clinical Trial Site | Denver | Colorado | |
| Clinical Trial Site | Fort Lauderdale | Florida | |
| Clinical Trial Site | St. Petersburg | Florida | |
| Clinical Trial Site | Chicago | Illinois | |
| Clinical Trial Site | Oak Park | Illinois | |
| Clinical Trial Site | Carmel | Indiana | |
| Clinical Trial Site | Prairie Village | Kansas | |
| Clinical Trial Site | Baltimore | Maryland | |
| Clinical Trial Site | Boston | Massachusetts | |
| Clinical Trial Site | Waltham | Massachusetts | |
| Clinical Trial Site | Ann Arbor | Michigan | |
| Clinical Trial Site | Detroit | Michigan | |
| Clinical Trial Site | Detroit | Michigan | |
| Clinical Trial Site | Minneapolis | Minnesota | |
| Clinical Trial Site | Rochester | Minnesota | |
| Clinical Trial Site | St Louis | Missouri | |
| Clinical Trial Site | Omaha | Nebraska | |
| Clinical Trial Site | Palisades Park | New Jersey | |
| NYU Langone Health | New York | New York | |
| Clinical Trial Site | Rochester | New York | |
| Clinical Trial Site | Durham | North Carolina | |
| Clinical Trial Site | Winston-Salem | North Carolina | |
| Clinical Trial Site | Cleveland | Ohio | |
| Clinical Trial Site | Cleveland | Ohio | |
| Clinical Trial Site | Columbus | Ohio | |
| Clinical Trial Site | Portland | Oregon | |
| Clinical Trial Site | Portland | Oregon | |
| Clinical Trial Site | Erie | Pennsylvania |
+ 67 more sites — see the full list on the official registry below.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06431373 on ClinicalTrials.gov ↗ ← All trials in the UK